Literature DB >> 1721385

Changes in renal function after liver transplantation under FK 506.

J McCauley1, J J Fung, S Todo, A Jain, P Deballi, T E Starzl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1721385      PMCID: PMC3022442     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.

Authors:  J J Fung; S Todo; A Jain; J McCauley; M Alessiani; C Scotti; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

2.  The effects of FK 506 on renal function after liver transplantation.

Authors:  J McCauley; J Fung; A Jain; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

Review 3.  Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics.

Authors:  T E Starzl; K Abu-Elmagd; A Tzakis; J J Fung; K A Porter; S Todo
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

4.  FK 506 for liver, kidney, and pancreas transplantation.

Authors:  T E Starzl; S Todo; J Fung; A J Demetris; R Venkataramman; A Jain
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

5.  The question of FK 506 nephrotoxicity after liver transplantation.

Authors:  J McCauley; S Takaya; J Fung; A Tzakis; K Abu-Elmagd; A Jain; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

  5 in total
  9 in total

1.  Acute renal failure in liver transplant patients: Indian study.

Authors:  Pradeep Naik; B Premsagar; M Mallikarjuna
Journal:  Indian J Clin Biochem       Date:  2013-11-23

2.  Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy.

Authors:  P S Randhawa; A C Tsamandas; M Magnone; M Jordan; R Shapiro; T E Starzl; A J Demetris
Journal:  Am J Surg Pathol       Date:  1996-03       Impact factor: 6.394

3.  What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.

Authors:  A Jain; J Reyes; R Kashyap; S Rohal; K Abu-Elmagd; T Starzl; J Fung
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

4.  The pharmacokinetics of water-in-oil-in-water-type multiple emulsion of a new tacrolimus formulation.

Authors:  T Uno; T Yamaguchi; X K Li; Y Suzuki; H Hashimoto; Y Harada; T Kimura; T Kazui
Journal:  Lipids       Date:  1997-05       Impact factor: 1.880

5.  Pharmacokinetic advantages of a newly developed tacrolimus oil-in-water-type emulsion via the enteral route.

Authors:  T Uno; T Kazui; Y Suzuki; H Hashimoto; K Suzuki; B A Muhammad
Journal:  Lipids       Date:  1999-03       Impact factor: 1.880

Review 6.  Renal dysfunction associated with liver transplantation.

Authors:  R M Jindal; I Popescu
Journal:  Postgrad Med J       Date:  1995-09       Impact factor: 2.401

7.  Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted?

Authors:  H R Doyle; I R Marino; N Jabbour; G Zetti; J McMichael; S Mitchell; J Fung; T E Starzl
Journal:  Transplantation       Date:  1994-04-15       Impact factor: 4.939

Review 8.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

9.  Tacrolimus-Induced Type IV Renal Tubular Acidosis following Liver Transplantation.

Authors:  Christopher Schmoyer; Suraj Mishra; Frank Fulco
Journal:  Case Reports Hepatol       Date:  2017-07-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.